Skip to main content
. 2013 Apr 22;15(12):985–990. doi: 10.1111/hpb.12080

Table 1.

Proportions of 8900 patients enrolled in a prospective screening trial for hepatocellular carcinoma with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection, and severity of viral-induced liver injury

Hepatitis type Patients, n (%)
 HBV infection 1335 (15.0%)

 HCV infection 7120 (80.0%)

 HBV + HCV infection 445 (5.0%)

Hepatic parenchyma

 Chronic active hepatitis: mild 5073 (57.0%)

 Chronic active hepatitis: severe 2225 (25.0%)

 Cirrhosis 1602 (18.0%)